Search
Search
About
Log in
Join
Experiences with
Hepatocellular carcinoma (HCC)
Posts
Communities
70 public posts
Filter results
Liver Transplant – Letter to Donor family – totally gutted.
I had my liver transplant back in 2016 due to alcohol abuse and
Hepatocellular
Carcinoma
. For a good 10-months post-transplant, I suffered terribly with survivors guilt and PTSD. I honestly felt that writing that letter to the donor family was an honest reflection of my gratitude.
I had my liver transplant back in 2016 due to alcohol abuse and
Hepatocellular
Carcinoma
. For a good 10-months post-transplant, I suffered terribly with survivors guilt and PTSD. I honestly felt that writing that letter to the donor family was an honest reflection of my gratitude.
Richard-Allen
in
British Liver Trust
3 years ago
Salmon Protein Hydrolysate
Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of
hepatocellular
carcinoma
. Histopathology 2019, 75, 63–73. [Google Scholar] [CrossRef] Shen, Y.; Li, X.; Dong, D.; Zhang, B.; Xue, Y.; Shang, P.
Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of
hepatocellular
carcinoma
. Histopathology 2019, 75, 63–73. [Google Scholar] [CrossRef] Shen, Y.; Li, X.; Dong, D.; Zhang, B.; Xue, Y.; Shang, P.
pjoshea13
in
Advanced Prostate Cancer
2 years ago
CAR-T Cell Therapy Trials
, Ductal|
Carcinoma
,
Hepatocellular
|Cancer|Lung Cancer, Non-Small-Cell|
Carcinoma
, Ovarian Epithelial|Carcinoma, Small Cell|Carcinoma, Squamous|Carcinoma, Transitional Cell|Colorectal Cancer|Esophagogastric Junction Neoplasms|Inflammatory Breast Cancer|Stomach Neoplasms|Malignant Neoplasms|Ovarian Neoplasms
, Ductal|
Carcinoma
,
Hepatocellular
|Cancer|Lung Cancer, Non-Small-Cell|
Carcinoma
, Ovarian Epithelial|Carcinoma, Small Cell|Carcinoma, Squamous|Carcinoma, Transitional Cell|Colorectal Cancer|Esophagogastric Junction Neoplasms|Inflammatory Breast Cancer|Stomach Neoplasms|Malignant Neoplasms|Ovarian Neoplasms
Hidden
in
Advanced Prostate Cancer
3 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Share Your HCC Story with AstraZeneca
At AstraZeneca, we believe that one of the best ways to raise awareness about
hepatocellular
carcinoma
(HCC) and elevate the HCC patient voice is to share authentic, real-world experiences of individuals.
At AstraZeneca, we believe that one of the best ways to raise awareness about
hepatocellular
carcinoma
(HCC) and elevate the HCC patient voice is to share authentic, real-world experiences of individuals.
AndreaWilson_Founder
Caregiver
in
Blue Faery Liver Cancer
4 years ago
Hepatocellular Carcinoma
Through an MRI in January they discovered an 8 mm x 8 mm lesion on my liver. In April a follow up MRI showed the lesion to be 12 mm x 11 mm. Tomorrow I am scheduled for an ablation of the lesion. I’m praying this ablation will kill this cancer. I will have a follow up MRI in a month to see if the lesion
Through an MRI in January they discovered an 8 mm x 8 mm lesion on my liver. In April a follow up MRI showed the lesion to be 12 mm x 11 mm. Tomorrow I am scheduled for an ablation of the lesion. I’m praying this ablation will kill this cancer. I will have a follow up MRI in a month to see if the lesion
Miamomma
in
PBCers Organization
4 years ago
HCC Patient Support Services- request from the British Liver Trust
As a group, patients with
Hepatocellular
Carcinoma
(HCC) are not well-represented in the cancer patient community and are not fully understood in terms of their priorities and what is important to them at all points during their treatment journey.
As a group, patients with
Hepatocellular
Carcinoma
(HCC) are not well-represented in the cancer patient community and are not fully understood in terms of their priorities and what is important to them at all points during their treatment journey.
Hidden
British Liver Trust
in
British Liver Trust
4 years ago
FDA Study Provides $50 for HCC Patient Interviews
The research team is seeking to recruit three individuals living with
hepatocellular
carcinoma
to take part in research interviews. Each interview will be conducted over the telephone and will last 60 minutes. Research participants will receive $50 compensation.
The research team is seeking to recruit three individuals living with
hepatocellular
carcinoma
to take part in research interviews. Each interview will be conducted over the telephone and will last 60 minutes. Research participants will receive $50 compensation.
AndreaWilson_Founder
Caregiver
in
Blue Faery Liver Cancer
4 years ago
VEGF Inhibitors.
Recently, research has revealed that in
hepatocellular
carcinoma
, it exerts its anti-angiogenesis effect though suppressing the STAT3/HIF-1α/VEGF signaling network [139].
Recently, research has revealed that in
hepatocellular
carcinoma
, it exerts its anti-angiogenesis effect though suppressing the STAT3/HIF-1α/VEGF signaling network [139].
pjoshea13
in
Advanced Prostate Cancer
4 years ago
Y90 TARE or Proton Beam Therapy?
My father Age: 70+ has been diagnosed with the following: Diagnosis: Non cirrhotic Liver with Right Lobe Tumour in Segment VIII, extending to V, no vascular invasion (Size: 9.4x9.1x9.8 cms)
Hepatocellular
Carcinoma
AFP: 2.46 IU/ml Ca 19.9: 16.1 (Tumour marker tests, AFP, Ca 19.9, CEA tests
My father Age: 70+ has been diagnosed with the following: Diagnosis: Non cirrhotic Liver with Right Lobe Tumour in Segment VIII, extending to V, no vascular invasion (Size: 9.4x9.1x9.8 cms)
Hepatocellular
Carcinoma
AFP: 2.46 IU/ml Ca 19.9: 16.1 (Tumour marker tests, AFP, Ca 19.9, CEA tests
Jabba2
in
Blue Faery Liver Cancer
5 years ago
Seeking HCC Patients Taking Lenvima
If you reside in the US, have been diagnosed with Stage III or IV unresectable
Hepatocellular
Carcinoma
(primary liver cancer), and you are currently taking Lenvima, we have a paid opinion market research study that may be of interest to you.
If you reside in the US, have been diagnosed with Stage III or IV unresectable
Hepatocellular
Carcinoma
(primary liver cancer), and you are currently taking Lenvima, we have a paid opinion market research study that may be of interest to you.
AndreaWilson_Founder
Caregiver
in
Blue Faery Liver Cancer
5 years ago
CRPC & 'Drug Repositioning'
), advanced primary liver cancer (
hepatocellular
carcinoma
), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma." [2] [3] Olaparib "(AZD-2281, MK-7339 trade name Lynparza) is an FDA-approved targeted therapy for cancer.
), advanced primary liver cancer (
hepatocellular
carcinoma
), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma." [2] [3] Olaparib "(AZD-2281, MK-7339 trade name Lynparza) is an FDA-approved targeted therapy for cancer.
pjoshea13
in
Advanced Prostate Cancer
5 years ago
Seeking HCC patients for paid research study
Pillar Patient Advocates is seeking patients who have been diagnosed with unresectable
Hepatocellular
Carcinoma
to participate in a paid research study.
Pillar Patient Advocates is seeking patients who have been diagnosed with unresectable
Hepatocellular
Carcinoma
to participate in a paid research study.
AndreaWilson_Founder
Caregiver
in
Blue Faery Liver Cancer
6 years ago
3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system
VaccaLidia de BariEmail author First Online: 03 November 2015 Abstract 3-bromopyruvate (3-BP) is an anti-tumour drug effective on
hepatocellular
carcinoma
and other tumour cell types, which affects both glycolytic and mitochondrial targets, depleting cellular ATP pool.
VaccaLidia de BariEmail author First Online: 03 November 2015 Abstract 3-bromopyruvate (3-BP) is an anti-tumour drug effective on
hepatocellular
carcinoma
and other tumour cell types, which affects both glycolytic and mitochondrial targets, depleting cellular ATP pool.
Graham49
in
Advanced Prostate Cancer
6 years ago
Inhibition of Cancer Stem Cells Promoted by Pimozide.
Our previous study reported that the neuroleptic drug pimozide had antitumor activity against
hepatocellular
carcinoma
cells or stem-like cells through suppressing the STAT3 activity.
Our previous study reported that the neuroleptic drug pimozide had antitumor activity against
hepatocellular
carcinoma
cells or stem-like cells through suppressing the STAT3 activity.
pjoshea13
in
Advanced Prostate Cancer
6 years ago
Cannabidiol (CBD).
Here we report a novel role for CBD as a potent inhibitor of EMV release from three cancer cell lines: prostate cancer (PC3),
hepatocellular
carcinoma
(HEPG2) and breast adenocarcinoma (MDA-MB-231).
Here we report a novel role for CBD as a potent inhibitor of EMV release from three cancer cell lines: prostate cancer (PC3),
hepatocellular
carcinoma
(HEPG2) and breast adenocarcinoma (MDA-MB-231).
pjoshea13
in
Advanced Prostate Cancer
6 years ago
HCC?
and my suspicions were confirmed when we got home and I checked on line -
HepatoCellular
Carcinoma
!! Surely if he has cancer, his consultant or GP would have said something? Thankfully, hubby has not picked up on this.
and my suspicions were confirmed when we got home and I checked on line -
HepatoCellular
Carcinoma
!! Surely if he has cancer, his consultant or GP would have said something? Thankfully, hubby has not picked up on this.
Hidden
in
British Liver Trust
7 years ago
Seeking Adults With Primary Liver Cancer
.,
Hepatocellular
Carcinoma
), you may qualify for a research study. You will be paid up to $175 for your participation in an individual telephone interview. L&E Research wants to hear from patients with liver cancer to learn more about their symptoms. The telephone interview will last one hour.
.,
Hepatocellular
Carcinoma
), you may qualify for a research study. You will be paid up to $175 for your participation in an individual telephone interview. L&E Research wants to hear from patients with liver cancer to learn more about their symptoms. The telephone interview will last one hour.
AndreaWilson_Founder
Caregiver
in
Blue Faery Liver Cancer
7 years ago
Non-Alcoholic Fatty Liver Disease (NAFLD)
"The numbers will drive -- among other things -- a 178% increase in the incidence of
hepatocellular
carcinoma
(HCC), Friedman said during a media briefing aimed at raising a red flag over the issue."
"The numbers will drive -- among other things -- a 178% increase in the incidence of
hepatocellular
carcinoma
(HCC), Friedman said during a media briefing aimed at raising a red flag over the issue."
pjoshea13
in
Advanced Prostate Cancer
7 years ago
Liver transplant and HCC
Hello All, my parents are based in Abroad, my Mom has had a diagnosis of
Hepatocellular
carcinoma
and has been advised that will need a transplant . They have health insurance that will cover them almost anywhere.
Hello All, my parents are based in Abroad, my Mom has had a diagnosis of
Hepatocellular
carcinoma
and has been advised that will need a transplant . They have health insurance that will cover them almost anywhere.
TPaterson
in
British Liver Trust
7 years ago
Timing of DAA therapy and HCC response may impact recurrence rate
"Unexpectedly high
hepatocellular
carcinoma
(#HCC) recurrence rates were reported among #patients who achieved sustained virologic response (SVR) after receiving direct-acting antiviral therapy (DAA), according to data presented at the International #Liver Congress." http://bit.ly/2qbd0EC
"Unexpectedly high
hepatocellular
carcinoma
(#HCC) recurrence rates were reported among #patients who achieved sustained virologic response (SVR) after receiving direct-acting antiviral therapy (DAA), according to data presented at the International #Liver Congress." http://bit.ly/2qbd0EC
HFIAdmin
in
HFI Connect - Hepatitis
7 years ago
1
2
3
4
Next page
Filter results
Clear filters
Posted in
All communities
Blue Faery Liver Cancer
23 results
Advanced Prostate Cancer
14 results
British Liver Trust
13 results
View top 10 communities
Sort by
Most Relevant
Newest